Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
637M
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
208M
-
Shares change
-
+19.4M
-
Total reported value, excl. options
-
$503M
-
Value change
-
+$47.3M
-
Put/Call ratio
-
0.22
-
Number of buys
-
90
-
Number of sells
-
-60
-
Price
-
$2.42
Significant Holders of GERON CORP - Common Stock, $0.001 par value (GERN) as of Q4 2022
222 filings reported holding GERN - GERON CORP - Common Stock, $0.001 par value as of Q4 2022.
GERON CORP - Common Stock, $0.001 par value (GERN) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 208M shares
of 637M outstanding shares and own 32.61% of the company stock.
Largest 10 shareholders include BlackRock Inc. (27.3M shares), STATE STREET CORP (19.7M shares), Vivo Capital, LLC (19.3M shares), VANGUARD GROUP INC (18.9M shares), NEA Management Company, LLC (16.3M shares), TCG Crossover Management, LLC (15.2M shares), RA CAPITAL MANAGEMENT, L.P. (12.9M shares), BIOIMPACT CAPITAL LLC (8.47M shares), Boxer Capital, LLC (8.1M shares), and Deep Track Capital, LP (7.41M shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.